Social Media Listening for Routine Post-Marketing Safety Surveillance

被引：0
|
作者：
Gregory E. Powell
Harry A. Seifert
Tjark Reblin
Phil J. Burstein
James Blowers
J. Alan Menius
Jeffery L. Painter
Michele Thomas
Carrie E. Pierce
Harold W. Rodriguez
John S. Brownstein
Clark C. Freifeld
Heidi G. Bell
Nabarun Dasgupta
机构：
[1] GlaxoSmithKline,
[2] GlaxoSmithKline Vaccines,undefined
[3] GlaxoSmithKline,undefined
[4] GlaxoSmithKline,undefined
[5] Blue Zone Industries,undefined
[6] Epidemico Inc.,undefined
[7] Zero Chaos,undefined
来源：
Drug Safety | 2016年 / 39卷
关键词：
Social Medium; Anatomical Therapeutic Chemical; Indicator Score; Proportional Reporting Ratio; Twitter Data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：443 / 454
页数：11
相关论文
共 50 条
  • [21] Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
    Fernanda Tavares-Da-Silva
    Olivia Mahaux
    Lionel Van Holle
    François Haguinet
    Harry Seifert
    Jens-Ulrich Stegmann
    [J]. Drug Safety, 2020, 43 : 1223 - 1234
  • [22] POST-MARKETING SURVEILLANCE OF NEW MEDICINES
    SMITHELLS, RW
    [J]. BRITISH MEDICAL JOURNAL, 1977, 2 (6096): : 1218 - 1218
  • [23] POST-MARKETING SURVEILLANCE BY DRUG MANUFACTURERS
    不详
    [J]. LANCET, 1988, 2 (8617): : 977 - 977
  • [24] Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
    Tavares-Da-Silva, Fernanda
    Mahaux, Olivia
    Van Holle, Lionel
    Haguinet, Francois
    Seifert, Harry
    Stegmann, Jens-Ulrich
    [J]. DRUG SAFETY, 2020, 43 (12) : 1223 - 1234
  • [25] WORLDWIDE POST-MARKETING SAFETY SURVEILLANCE EXPERIENCE WITH TOFACITINIB IN ULCERATIVE COLITIS
    Rubin, David T.
    Modesto, Irene
    Vermeire, Severine
    Danese, Silvio
    Ng, Siew C.
    Kwok, Kenneth K.
    Koram, Nana
    Jones, Thomas V.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S36 - S36
  • [26] Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis
    Rubin, David T.
    Modesto, Irene
    Vermeire, Severine
    Danese, Silvio
    Ng, Siew C.
    Kwok, Kenneth K.
    Koram, Nana
    Jones, Thomas, V
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (03) : 302 - 310
  • [27] Post-marketing safety surveillance of erenumab: new insight from Eudravigilance
    Liang, David
    Sessa, Maurizio
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (09) : 1205 - 1210
  • [28] Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
    Chunxiao Li
    Tao Xu
    Peng Zhou
    Junhua Zhang
    Ge Guan
    Hui Zhang
    Xiao Ling
    Weixia Li
    Fei Meng
    Guanping Liu
    Linyan Lv
    Jun Yuan
    Xuelin Li
    Mingjun Zhu
    [J]. BMC Complementary and Alternative Medicine, 18
  • [29] Post-Marketing Surveillance of Prescription Drug Safety: Past, Present, and Future
    Chen, Brian K.
    Yang, Y. Tony
    [J]. JOURNAL OF LEGAL MEDICINE, 2013, 34 (02) : 193 - 213
  • [30] Post-marketing safety surveillance and re-evaluation of Xueshuantong injection
    Li, Chunxiao
    Xu, Tao
    Zhou, Peng
    Zhang, Junhua
    Guan, Ge
    Zhang, Hui
    Ling, Xiao
    Li, Weixia
    Meng, Fei
    Liu, Guanping
    Lv, Linyan
    Yuan, Jun
    Li, Xuelin
    Zhu, Mingjun
    [J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 18
12345